Share on LinkedInShare on LinkedIn

ARTICLE · 15 MAY 2018

Recent Developments In Intellectual Property Related To Medicine

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

The past year has seen a surge in innovation in the medical and life science fields

United StatesIntellectual Property

The past year has seen a surge in innovation in the medical and life science fields.  Newly published patent application and granted patents reveal applications of artificial intelligence software as a medical device, and nanotechnology to these fields. 

In 2017, IBM received a patent for drug discovery using machine learning.  U.S. Patent No. 9,536,194 is directed to a system and method for analyzing chemical data.  The artificial intelligence uses machine learning to predict whether a given chemical can treat a particular condition including a predictive module to determine whether a given chemical could be used to treat a given disease and what side effects are likely to occur.  The '194 patent is an example of the growing use of artificial intelligence in drug discovery and computational chemistry.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from